BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35996247)

  • 21. DSCAM-AS1 regulates the G
    Sun W; Li AQ; Zhou P; Jiang YZ; Jin X; Liu YR; Guo YJ; Yang WT; Shao ZM; Xu XE
    Cancer Med; 2018 Dec; 7(12):6137-6146. PubMed ID: 30430768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling.
    Ning Y; Bai Z
    Cancer Biomark; 2021; 30(1):29-39. PubMed ID: 32865178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA DSCAM-AS1 Negatively Interacts with miR-124 to Promote Hepatocellular Carcinoma Proliferation.
    Wang Z; Li S; Zhang G
    Crit Rev Eukaryot Gene Expr; 2022; 32(3):1-8. PubMed ID: 35695605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA SBF2-AS1: A Budding Star in Various Cancers.
    Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C
    Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis.
    Hu J; Peng F; Qiu X; Yang J; Li J; Shen C; Yuan C
    Curr Med Chem; 2023; 30(37):4266-4276. PubMed ID: 36644870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
    Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
    DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of long non-coding RNA FGD5-AS1 in cancer.
    He N; Xiang L; Chen L; Tong H; Wang K; Zhao J; Song F; Yang H; Wei X; Jiao Z
    Bioengineered; 2022 Apr; 13(4):11026-11041. PubMed ID: 35475392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer.
    Luo D; Liu Y; Yuan S; Bi X; Yang Y; Zhu H; Li Z; Ji L; Yu X
    Pathol Res Pract; 2022 Jul; 235():153938. PubMed ID: 35552086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis.
    Huang X; Wang Z; Hou S; Yue C; Li Z; Hu W; Lu H
    Bioengineered; 2022 Feb; 13(2):4153-4165. PubMed ID: 35142595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types.
    Tan F
    Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
    Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
    Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile.
    Treeck O; Weber F; Fritsch J; Skrzypczak M; Schüler-Toprak S; Buechler C; Ortmann O
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells.
    Liu F; Jia J; Sun L; Yu Q; Duan H; Jiao D; Gong Z; Zhu S; Jiang K; He Y; Chen L; Zhang Y; Sun H
    Onco Targets Ther; 2019; 12():6789-6795. PubMed ID: 31686837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA HOXD-AS1 in cancer.
    Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
    Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway.
    Du LJ; Mao LJ; Jing RJ
    Biochem Biophys Res Commun; 2020 Dec; 533(3):565-572. PubMed ID: 32981678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non‑coding RNA DSCAM‑AS1 functions as an oncogene in thyroid cancer via regulating miR‑211.
    Hua T; Yang J; Zhu Y; Luo Y
    Oncol Lett; 2023 Apr; 25(4):165. PubMed ID: 36960191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer.
    Lu X; Wang J; Wang W; Lu C; Qu T; He X; Liu X; Guo R; Zhang E
    Oncogene; 2022 Jun; 41(23):3222-3238. PubMed ID: 35508543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.